CEO of PharMerica Corp. (PMC, Financial) Gregory S Weishar buys 25,000 shares of PMC on 11/13/2009 at an average price of $14.87 a share.
PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare, Inc. and pharmaceutical services company AmerisourceBergen Corporation. As a result of this combination, PharMerica ranks as an industry-leading U.S. provider of institutional pharmacy services in terms of annual revenues. Pharmerica Corp. has a market cap of $454.42 million; its shares were traded at around $14.88 with a P/E ratio of 12.1 and P/S ratio of 0.23.
PMC is in the portfolios of John Keeley of Keeley Fund Management.
PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare, Inc. and pharmaceutical services company AmerisourceBergen Corporation. As a result of this combination, PharMerica ranks as an industry-leading U.S. provider of institutional pharmacy services in terms of annual revenues. Pharmerica Corp. has a market cap of $454.42 million; its shares were traded at around $14.88 with a P/E ratio of 12.1 and P/S ratio of 0.23.
PMC is in the portfolios of John Keeley of Keeley Fund Management.
Insiders' Positions with PMC
- Sell:: SVP and CAO Berard Tomassetti sold 110 shares of PMC stock on 08/11/2009 at the average price of 21.21, the price of the stock has decreased by 29.84% since
